KLOTHO NEUROSCIENCES INC (KLTO) Stock Price, Quote, News and Overview
NASDAQ:KLTO - Nasdaq - US49876K1034 - Common Stock - Currency: USD
KLTO Quote, Performance and Key Statistics
0.156
0 (-0.57%)
The current stock price of KLTO is 0.156 USD. In the past month the price decreased by -45.01%.
KLTO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.17 | 307.41B | ||
| AMGN | AMGEN INC | 14.05 | 149.68B | ||
| GILD | GILEAD SCIENCES INC | 22.89 | 131.53B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1691.28 | 126.09B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.83 | 64.01B | ||
| ARGX | ARGENX SE - ADR | 322.51 | 36.63B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 30.80B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.24B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.16B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 20.17B | ||
| NTRA | NATERA INC | N/A | 19.55B | ||
| BIIB | BIOGEN INC | 7.22 | 17.40B |
Related stock screener links
About KLTO
Company Profile
Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. The company is headquartered in New York City, New York. The company went IPO on 2022-04-29. The firm is engaged in the development of disease-modifying cell and gene therapies using a patented secreted form of the anti-aging Klotho gene (s-KL) to transform the treatment of neurodegenerative and age-related disorders, such as amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's disease. The Company’s portfolio consists of its proprietary cell and gene therapy programs using deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) as therapeutics and diagnostics. Its gene therapy programs include KLTO-202, KLTO-101, and KLTO-301. Other assets include clinical-stage programs involving antibody biologics targeting cancer and autoimmune diseases, and drug delivery via a needle-free dry powder jet autoinjector called Nanoject. The firm has licensed the anti-aging protein called α-Klotho for gene therapy to stop the progression of, or prevent, neurodegenerative diseases.
Company Info
KLOTHO NEUROSCIENCES INC
1115 Broadway, 12th Floor
New York City NEW YORK US
Employees: 0
Company Website: https://klothoneuro.com/
Investor Relations: http://www.anewmeds.com/news-resources/
Phone: 16469165315
KLOTHO NEUROSCIENCES INC / KLTO FAQ
What is the stock price of KLOTHO NEUROSCIENCES INC today?
The current stock price of KLTO is 0.156 USD. The price decreased by -0.57% in the last trading session.
What is the ticker symbol for KLOTHO NEUROSCIENCES INC stock?
The exchange symbol of KLOTHO NEUROSCIENCES INC is KLTO and it is listed on the Nasdaq exchange.
On which exchange is KLTO stock listed?
KLTO stock is listed on the Nasdaq exchange.
What is KLOTHO NEUROSCIENCES INC worth?
KLOTHO NEUROSCIENCES INC (KLTO) has a market capitalization of 4.45M USD. This makes KLTO a Nano Cap stock.
How many employees does KLOTHO NEUROSCIENCES INC have?
KLOTHO NEUROSCIENCES INC (KLTO) currently has 0 employees.
What are the support and resistance levels for KLOTHO NEUROSCIENCES INC (KLTO) stock?
KLOTHO NEUROSCIENCES INC (KLTO) has a resistance level at 0.2. Check the full technical report for a detailed analysis of KLTO support and resistance levels.
Should I buy KLOTHO NEUROSCIENCES INC (KLTO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KLTO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KLTO, evaluating the profitability, health, valuation and growth aspects
- KLOTHO NEUROSCIENCES INC (KLTO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KLOTHO NEUROSCIENCES INC (KLTO) Sales and EPS estimates to see what analysts future expectations are.
- KLOTHO NEUROSCIENCES INC (KLTO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KLOTHO NEUROSCIENCES INC (KLTO) Insider and Institutional Ownership to learn about the owners and their transactions.
- KLOTHO NEUROSCIENCES INC (KLTO) Stock Chart to make your own analysis
- KLOTHO NEUROSCIENCES INC (KLTO) Latest news and press-releases to stay up to date.
Does KLOTHO NEUROSCIENCES INC (KLTO) stock pay dividends?
KLTO does not pay a dividend.
What is the Price/Earnings (PE) ratio of KLOTHO NEUROSCIENCES INC (KLTO)?
KLOTHO NEUROSCIENCES INC (KLTO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.24).
What is the Short Interest ratio of KLOTHO NEUROSCIENCES INC (KLTO) stock?
The outstanding short interest for KLOTHO NEUROSCIENCES INC (KLTO) is 2.49% of its float. Check the ownership tab for more information on the KLTO short interest.
KLTO Technical Analysis
KLTO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to KLTO. The financial health of KLTO is average, but there are quite some concerns on its profitability.
KLTO Financial Highlights
Over the last trailing twelve months KLTO reported a non-GAAP Earnings per Share(EPS) of -0.24. The EPS decreased by -264.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -162.09% | ||
| ROE | -273.46% | ||
| Debt/Equity | 0 |